Cancer Therapies--Technology Assessment in North America (Technical Insights)

 

Regular Price: USD 3,950

Special Price USD 2,765

30% OFF

* Required Fields

Regular Price: USD 3,950

Special Price USD 2,765

PAY BY INVOICE

Be the first to review this product

This research service analyzes and profiles emerging technological trends for cancer therapies in North America

Table of Contents

Cancer Therapies--Technology Assessment in North America (Technical Insights), Executive SummaryIntroductionEmerging Approaches to Cancer Therapy and Management--An OverviewAn Overview of the Current Cancer Therapies MarketScope and MethodologyScope and Segmentation of the Research ServiceMethodologyCancer Therapies--Technology Assessment in North America (Technical Insights), New Developments in Primary Treatment ModalitiesRadiation TherapyTomotherapy in Treatment of CancerNovel System to Deliver Intensity-Modulated Radiation Therapy in a Better WaySkeletal Targeted RadiotherapyDose-Guided Radiation Therapy System from SiemensSurgeryA Better Radio frequency ablation TechnologyCyberknife Stereotactic Radiosurgery SystemCancer Therapies--Technology Assessment in North America (Technical Insights), Novel Techniques and ApproachesTargeted TherapiesTechnology PrimerOSI's Tyrosine Kinase Inhibitors in Phase I StudyOngoing Studies for Targeted Lung Cancer TherapyAnti-Cancer Compound Inhibits Both Tumor Proliferation and AngiogenesisAmpliMed’s Novel Anti-Cancer Drugs with Unique Mechanism of ActionProcyon’s PCK3145 Therapeutic Peptide for Advanced Metastatic Prostate CancerGene TherapyTechnology PrimerAgilent’s Novel Platform for Cancer Drug DiscoveryTumor Necrosis Therapy for Brain CancerMucin-Derived Peptide for Immune Protection against CancerAntibody as a Mono- or Co-Therapy for CancerCuraGen's Antibody Drug Conjugate for MelanomaLexicon Anti-Cancer Agent in Preclinical DevelopmentVaccinesTechnology PrimerAlteris Vaccine Increases Brain Cancer SurvivalAnti-Cancer Vaccine Uses Multiple Antigen GenesGVAX Prostate Cancer Vaccine in Phase III TrialsMedarex Antibody and Vaccine against MelanomaIntrogen's Therapeutic Cancer VaccineNanotechnologyNanoshells for Effective Treatment of CancerNanotechnology Gene Therapy for Prostate CancerNanotubes to Deliver Anticancer DrugsMinimally Invasive Techniques and DevicesHigh-Intensity Focused Ultrasound Therapy for Prostate CancerInnovative Balloon Catheter Device for Partial Breast IrradiationCryoneedles To Reduce Cryotherapy Time for Treating Prostate CancerThermal Technology for Cancer Therapy Getting 'Hotter'Cancer Therapies--Technology Assessment in North America (Technical Insights), Therapies in DevelopmentBreast CancerBreast Cancer Therapies--An OverviewAnalysis of Important Clinical TrialsColorectal CancerColorectal Cancer Therapies--An OverviewRecently Approved DrugsAnalysis of Important Clinical TrialsLung CancerLung Cancer Therapies--An OverviewAnalysis of Important Clinical TrialsMelanomaMelanoma Therapies--An OverviewAnalysis of Important Clinical TrialsProstate CancerProstate Cancer Therapies--An OverviewAnalysis of Important Clinical TrialsCytogen and Progenics PSMA PlatformCancer Therapies--Technology Assessment in North America (Technical Insights), Development of New Cancer Therapies--Technology AssessmentTrend AnalysisTechnology TrendsCorporate CollaborationsNovel Cancer Therapies--Drivers and ChallengesDriversChallengesCancer Therapies--Technology Assessment in North America (Technical Insights), Key Contacts and Noteworthy PatentsKey ContactsIndustry ContactsUniversity ContactsImportant PatentsPatents (Companies)Patents (Universities)Cancer Therapies--Technology Assessment in North America (Technical Insights), Frost & Sullivan Science and Technology AwardsExcellence In TechnologyAward DescriptionAward RecipientExcellence In ResearchAward DescriptionAward RecipientTechnology Innovation AwardAward DescriptionAward RecipientCancer Therapies--Technology Assessment in North America (Technical Insights), Critical Reference TablesBreast CancerBreast Cancer Incidence (1999-2006)Breast Cancer Mortality (1999-2006)Colon Rectum CancerColon Rectum Cancer Incidence (1999-2006)Colon Rectum Cancer Mortality (1999-2006)Liver CancerLiver Cancer Incidence (1999-2006)Liver Cancer Mortality (1999-2006)Lung CancerLung Cancer Incidence (1999-2006)Lung Cancer Mortality (1999-2006)Prostate CancerProstate Cancer Incidence (1999-2006)Prostate Cancer Mortality (1999-2006)




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 20-Nov-17

Region : North America

Release Date : 07-Nov-17

Region : North America

Release Date : 06-Nov-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.